These treatment strategies often generate serious adverse effects due to the pleiotropic functions of TGFβ in normal and cancer cells and have mitigated effects on tumor progression, perhaps because they do not consider the dual role of TGFβ in cancer. This evidence concerns the gene TGFB1 and cancer.